Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Genitourinary 1Endocrine 1Breast 1

Conditions

Thyroid Cancer Metastatic 1Osteoporosis 1Multiple Endocrine Neoplasia Type 1 1Bone Diseases, Metabolic 1

Interventions

X-Rays 1Vitamin D 1Observation 1Denosumab 1Calcium 1Biological Products 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoporosis × Denosumab × Endocrine × Clear all
NCT00980174 2018-10-17

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis

Amgen

Phase 3 Completed
242 enrolled 19 charts
Endocrine

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡